Orange Book Blog

American Conference Institute is holding its "15th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions" in San Francisco, California on July 20th and 21st.  According to ACI, this conference provides an opportunity to "meet the key dealmakers who will give you the contacts and intelligence you need to launch your company and product portfolio to the next level."

The agenda includes:

• Market watch: Understanding the driving forces and changing dynamics impacting the current deal-making landscape
• Integrating increasing M&A activity into your business development strategy
• Best practices for selecting the deal structure and negotiating your most beneficial collaborative agreements yet
• Negotiating options, staged acquisitions, hybrid transactions and straight-forward M&As
• Streamlining entry into lucrative emerging markets via strategic partnering
• Beyond the shadow of the valley: Alternative pathways and partnerships to facilitate funding drug discovery and development
• Preparing for the exit: Proactively drafting critical termination provisions to protect company assets
• Protecting current and future collaborations: The dos and dont's of partnering/negotiations
• Aligning divergent interests to negotiate mutually beneficial collaborative research agreements with academic institutions
• Utilizing applicable valuation models to set realistic expectations for a deal
• Mitigating legal risks in the life sciences M&A setting: a six-step approach
• Licensing strategies for biosimilars: Regulatory, commercial and IP considerations for the new frontier

In addition, there is a post-conference master class, "Conducting Effective & Strategic Due Diligence for Life Sciences Partnering and M&A," on July 22nd.

Orange Book Blog readers can receive a $200 discount by using code OBB 200.  For more information or to register, please visit the conference website.